Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-28

Clinical Trial Update: A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether adding oxycodone/naloxone prolonged-release tablets to pregabalin improves analgesia in opioid-naïve patients with moderate-to-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone/Naloxone prolonged-release tablets (oxycodone/naloxone)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: Mundipharma Research GmbH & Co KG | Conditions: Moderate to Severe Pain Due to Diabetic Polyneuropathy | Phase 2 | Status: COMPLETED | Results posted: 2012-02-28